icon
0%

Northern Trust Corp NTRS - News Analyzed: 3,852 - Last Week: 98 - Last Month: 495

↝ Northern Trust Corporation (NTRS): A Biotech Mix of Innovation, Earnings Surprises, and Stock Sales

Northern Trust Corporation (NTRS): A Biotech Mix of Innovation, Earnings Surprises, and Stock Sales
Northern Trust Corporation (NTRS) has been active recently, with notices of shares being sold by various institutional investors such as Natixis Advisors, National Bank of Canada FI and Victory Capital Management. Despite the stock underperforming when compared to competitors on some days, Northern Trust has also topped Q2 earnings and revenue estimates and witnessed increased investment by institutions like Los Angeles Capital Management. Notably, analyst sentiment around the corporation remains strong with Zacks upgrading its rating to a strong buy, and NTRS being considered a strong momentum stock. Furthermore, Northern Trust has seen notable developments including the purchases of Parilux Investment Technology and the appointment of Nancy Grady as Head of U.S. Fund Administration. Yet, Northern Trust fell short of Q1 earnings expectations which may have influenced its turbulent stock performance. Also, Northern Trust has a firm focus on continuous improvement and innovation, highlighted by enhancements to its cloud-based Insurance Accounting and Analytics Application.

Northern Trust Corp NTRS News Analytics from Tue, 12 Sep 2023 07:00:00 GMT to Sun, 12 May 2024 12:24:19 GMT - Rating 0 - Innovation 8 - Information 7 - Rumor -7

The email address you have entered is invalid.